PEN NYSE
Penumbra, Inc.
1W: +0.9%
1M: +2.0%
3M: +1.6%
YTD: +5.1%
1Y: +28.3%
3Y: +57.1%
5Y: +22.4%
$324.04
-1.18 (-0.36%)
After Hours: $328.57 (+4.53, +1.40%)
Weekly Expected Move ±0.7%
$320
$322
$325
$327
$329
Credit Risk of going bust: lower than 94% of companies Debt: 1.6% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.33 (down 99.9%), Penumbra, Inc. would be worth roughly what it owes.
Total debt $212.7M against a stock market value of $12.81B.
Distance to default 18.43 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $106.4M (short-term plus half of long-term), stock volatility 26.3%; Altman Z 19.31. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.33 (down 99.9%), Penumbra, Inc. would be worth roughly what it owes.
Total debt $212.7M against a stock market value of $12.81B.
Distance to default 18.43 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $106.4M (short-term plus half of long-term), stock volatility 26.3%; Altman Z 19.31. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships4
As Filer
counterparties named
2
As Counterparty
mentioned by others
3
Rel. Types
2021-10-07
Earliest Filing
2026-02-26
Latest Filing
target: 2
acquirer: 1
JV: 1
Counterparties (Filed by PEN)
4 relationshipsCompanies named in PEN's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Boston Scientific Corporation | BSX | acquirer | Acquiring Penumbra, Inc. in a merger transaction | 2026-01-15 | View |
| Pinehurst Merger Sub, Inc. | — | target | Wholly owned subsidiary of Boston Scientific Corporation used to merge with Penumbra, Inc. | 2026-01-15 | View |
| Sixense Enterprises Inc. | — | target | Target company acquired by Penumbra, Inc. in a merger transaction. | 2021-10-07 | View |
| MVI Health Inc. | — | JV | Joint venture formed by Penumbra and Sixense to explore healthcare applications of virtual reality technology. | 2021-10-07 | View |
Mentioned As Counterparty
2 mentionsOther companies that named PEN in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| BSX BOSTON SCIENTIFIC CORP | acquirer | Target company in the acquisition referenced as the closing condition for the 364-Day Revolving Credit Agreement. | 2026-02-26 | View |
| BSX BOSTON SCIENTIFIC CORP | acquirer | Target company in a merger agreement with Boston Scientific Corporation. | 2026-01-15 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-07-30 | Earnings Release; Exhibits | View | |
| 2026-06-22 | Shareholder Vote | View | |
| 2026-05-07 | Shareholder Vote | View | |
| 2026-05-06 | Earnings Release; Exhibits | View | |
| 2026-02-25 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-15 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Regulation | Agreement | View |
| 2025-11-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-27 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-07-29 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-30 | Amendments to Articles of Incorporation or Bylaws; Submission of Matters to a Vote of Security Holde | View | |
| 2025-04-23 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-21 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-02-18 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-10-30 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-08-13 | Other Events; Financial Statements and Exhibits | View | |
| 2024-07-30 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-05-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-02-22 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2023-11-02 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2023-08-03 | Submission of Matters to a Vote of Security Holders | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR